Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amjad Ali

Showing results (851-860 of 884) with videos related to

Pageof 89
Sort By:
Molecular Oncology|December 21, 2021
FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancerPer Flodbring Larsson, Richard Karlsson, Martuza Sarwar, et al.
Nature Communications|July 18, 2023
Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancerZhe Jiang, YoungJun Ju, Amjad Ali, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2011
SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitorsZhijian Lu, Yi-Heng Chen, Joann B Napolitano, et al.
BMC Genomics|January 10, 2015
Proteome scale comparative modeling for conserved drug and vaccine targets identification in Corynebacterium pseudotuberculosisSyed Shah Hassan, Sandeep Tiwari, Luís Carlos Guimarães, et al.
Cell Reports|April 4, 2024
Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancerAlok K Mishra, Tianyi Ye, Shahid Banday, et al.
Journal of Bacteriology|November 2, 2010
Complete genome sequence of Corynebacterium pseudotuberculosis I19, a strain isolated from a cow in Israel with bovine mastitisArtur Silva, Maria Paula C Schneider, Louise Cerdeira, et al.
Journal of Medicinal Chemistry|April 30, 2004
Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activityAmjad Ali, Christopher F Thompson, James M Balkovec, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacyChristopher F Thompson, Nazia Quraishi, Amjad Ali, et al.
Bioorganic & Medicinal Chemistry Letters|November 25, 2010
2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic miceFlorida Kallashi, Dooseop Kim, Jennifer Kowalchick, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Discovery of Spirocyclic Aldosterone Synthase Inhibitors as Potential Treatments for Resistant HypertensionWhitney L Petrilli, Scott B Hoyt, Clare London, et al.
Pageof 89

Showing results (851-860 of 884) with videos related to

Sort By:
Pageof 89
Molecular Oncology|December 21, 2021
FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancerPer Flodbring Larsson, Richard Karlsson, Martuza Sarwar, et al.
Nature Communications|July 18, 2023
Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancerZhe Jiang, YoungJun Ju, Amjad Ali, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2011
SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitorsZhijian Lu, Yi-Heng Chen, Joann B Napolitano, et al.
BMC Genomics|January 10, 2015
Proteome scale comparative modeling for conserved drug and vaccine targets identification in Corynebacterium pseudotuberculosisSyed Shah Hassan, Sandeep Tiwari, Luís Carlos Guimarães, et al.
Cell Reports|April 4, 2024
Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancerAlok K Mishra, Tianyi Ye, Shahid Banday, et al.
Journal of Bacteriology|November 2, 2010
Complete genome sequence of Corynebacterium pseudotuberculosis I19, a strain isolated from a cow in Israel with bovine mastitisArtur Silva, Maria Paula C Schneider, Louise Cerdeira, et al.
Journal of Medicinal Chemistry|April 30, 2004
Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activityAmjad Ali, Christopher F Thompson, James M Balkovec, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacyChristopher F Thompson, Nazia Quraishi, Amjad Ali, et al.
Bioorganic & Medicinal Chemistry Letters|November 25, 2010
2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic miceFlorida Kallashi, Dooseop Kim, Jennifer Kowalchick, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Discovery of Spirocyclic Aldosterone Synthase Inhibitors as Potential Treatments for Resistant HypertensionWhitney L Petrilli, Scott B Hoyt, Clare London, et al.
Pageof 89